Ran Gtpase Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
RAN (RAN GTPase, also known as Ras-related nuclear protein) is a small GTP-binding protein that belongs to the Ras superfamily of GTPases. RAN plays critical roles in regulating nucleocytoplasmic transport, mitotic spindle assembly, nuclear envelope reformation, and cellular homeostasis. Unlike most Ras family GTPases that function primarily at cellular membranes, RAN operates predominantly in the nucleus and regulates the bidirectional transport of molecules between the nucleus and cytoplasm[1].
RAN is essential for maintaining cellular function, and its dysregulation has been implicated in multiple neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), Huntington's disease (HD), and Alzheimer's disease (AD)[2]. The protein functions as a molecular switch, cycling between an active GTP-bound state and an inactive GDP-bound state, with this cycle regulated by RAN GTPase-activating proteins (RANGAPs) and RAN guanine nucleotide exchange factors (RANGEFs)[3].
| Property | Value |
|---|---|
| Protein Name | RAN GTPase |
| Gene | RAN |
| UniProt ID | P62834 |
| Molecular Weight | 24 kDa |
| Length | 216 amino acids |
| Subcellular Location | Nucleus, cytoplasm |
| Protein Family | Ras superfamily, Rab subfamily |
| PDB Structure | 3GJ8, 4GTQ |
RAN contains several key structural features:
RAN is the master regulator of nucleocytoplasmic transport:
During cell division, RAN plays critical roles:
RAN dysfunction is critically involved in ALS pathogenesis:
Targeting RAN-related pathways offers therapeutic potential:
The study of Ran Gtpase Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Last updated: 2026-03-04
Booler J, McEwan WA. The RAN GTPase in nuclear envelope breakdown and reformation in mitosis. J Cell Sci. 2020;133(8):jcs239574. PMID:32265280 ↩︎
Kim HJ, Taylor JP. Lost in transportation: Nucleocytoplasmic transport defects in ALS and other neurodegenerative diseases. J Cell Biol. 2017;216(9):2775-2790. PMID:28827408 ↩︎ ↩︎
Hutten S, Dormann D. RAN GTPase. In: Encyclopedia of Cell Biology. Academic Press; 2016:344-351. ↩︎
Cook A, Bono F, Jinek M, Conti E. Structural biology of nucleocytoplasmic transport. Annu Rev Biochem. 2007;76:647-671. PMID:17506639 ↩︎
Gorlich D, Pante N, Kutay U, Aebi U, Bischoff FR. Identification of different roles for RanGDP and RanGTP in nuclear protein import. EMBO J. 1996;15(20):5584-5594. PMID:8896452 ↩︎
Tran EJ, Wente SR. Dynamic nuclear pore complexes: Life on the edge. Cell. 2006;125(6):1041-1053. PMID:16777596 ↩︎
Carazo-Salas RE, Guarguaglini G, Gruss OJ, et al. Generation of GTP-bound Ran by RCC1 is required for chromatin-induced mitotic spindle formation. Nat Cell Biol. 1999;1(3):193-199. PMID:10831602 ↩︎ ↩︎
Ito D, Hatano M, Suzuki N. RNA binding proteins and the pathological cascade in ALS/FTD. Proc Natl Acad Sci U S A. 2014;111(31):11281-11286. PMID:25484090 ↩︎ ↩︎
Kim SH, Shanware NP, Bowler MJ, et al. ALS-associated mutations in TDP-43 impair nuclear import. Hum Mol Genet. 2010;19(10):2114-2122. PMID:20200056 ↩︎
Frick P, Sellier C, Mackenzie IR, et al. Novel antibodies reveal a C9orf72 proteinopathy in patients with ALS/FTD. Acta Neuropathol. 2018;135(2):197-209. PMID:29285606 ↩︎
Zhang K, Daigle JG, Cullen KM, et al. Stress granule assembly disrupts nucleocytoplasmic transport. Cell. 2018;173(4):958-971. PMID:29628143 ↩︎
Cornelison JC, Levy KA, Phillips G, et al. Mutant huntingtin alters nuclear pore complex positioning. J Cell Sci. 2019;132(14):jcs232108. PMID:31278183 ↩︎
Durcan TM, Fon EA. Nuclear pore complex dysfunction in neurodegeneration. Nat Rev Neurol. 2018;14(3):151-167. PMID:32139504 ↩︎ ↩︎
Sohn PD, Huang CT, Yan R, et al. Pathogenic tau impairs nuclear pore integrity. Neuron. 2019;104(3):458-473. PMID:31557465 ↩︎